Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 116.50
Bid: 115.00
Ask: 118.00
Change: 8.00 (7.37%)
Spread: 3.00 (2.609%)
Open: 108.50
High: 117.50
Low: 107.00
Prev. Close: 108.50
TRT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Update, new Website & Investor Presentation

17 Dec 2020 07:00

RNS Number : 9028I
Transense Technologies PLC
17 December 2020
 

 

Transense Technologies plc

("Transense", or "the Company")

 

AGM Trading Update

Launch of new website

Investor Presentation

Transense Technologies plc (AIM: TRT), the developer of specialist sensor systems, announces the following trading update ahead of its Annual General Meeting, being held at 10 a.m. today.

 

Trading update

 

Revenues from Surface Acoustic Wave (SAW) technology and Translogik probe products are substantially ahead of the modest level achieved in the equivalent period last year. Additionally, the rate of royalty income from iTrack has been increasing as expected, with expectations of further growth as the licencee continues to implement its roll-out and marketing strategy. The net result for the financial year to date is around break even and cash neutral, in line with management expectations, and the Board is optimistic about the outlook for the full year and beyond.

 

SAWCAP

 

The newly formed SAW Commercial Advisory Panel ("SAWCAP") held its first group meeting last week. The role of SAWCAP is to provide advice to the Board and management in support of i) the development of commercial strategy; ii) the implementation of sales and marketing activities to promote revenue growth; and iii) to forge strategic alliances that enhance long term shareholder value, with a particular focus on the Company's SAW technology. 

 

The initial observations of SAWCAP indicate that the commercial opportunities for SAW technology span a broad range of sectors, and are driven by the utilisation of real time data to monitor and enhance performance, diagnose condition and faults, and reduce energy consumption. The target markets previously identified in the SAW strategic business plan have been validated, and in each market there are several potential applications and customers. Work has now commenced to evaluate and prioritise which areas are both technically feasible and most likely to generate significant commercial value over the medium term.

 

Our parallel short term objective is to establish projects which enable the SAW business to cover its directly attributable costs, without reliance on other sources of group income. In the meanwhile, project costs and operating overheads are manageable, and will only be increased in a controlled manner as future success becomes more tangible.

 

Launch of new website

 

The Company has today launched a major revamp of its website, www.transense.com, with enhancements to the range and presentation of information on the Company and its business and improved navigation tools. The new website also provides investors with an opportunity to register their interest in receiving updates on the Company and access to equity research reports on the Company. In addition, the website continues to contain the information required to be disclosed pursuant to Rule 26 of the AIM Rules for Companies.

 

Executive Chairman, Nigel Rogers, commented:

 

"We have taken some important first steps in building sustainable long term value for all of our stakeholders. We are now operating from a secure financial platform, with clear visibility of future revenue growth and medium term commercial opportunities to enhance these returns."

 

AGM Investor Presentation: 4.00pm today, Thursday 17 December 2020

 

Nigel Rogers (Executive Chairman) and Melvyn Segal (Chief Financial Officer) will hold a presentation about Transense and its prospects at 4.00pm today, Thursday 17 December 2020. The presentation will be hosted through the digital platform Investor Meet Company. Investors can sign up to Investor Meet Company for free and add to meet Transense Technologies plc via the following link: https://www.investormeetcompany.com/transense-technologies-plc/register-investor. Investors who have already registered and added to meet the Company will automatically be invited.

 

Questions can be submitted pre-event to transense@walbrookpr.com or in real time during the presentation via the "Ask a Question" function. 

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

For further information please visit www.transense.com or contact:

 

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Melvyn Segal (CFO)

Via Walbrook PR

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter/James Reeve (Corporate Finance)

Tony Quirke (Equity Sales)

Tel: +44 (0)20 3328 5656

Walbrook PR

Tom Cooper/Nick Rome/Nicholas Johnson

Tel: +44 (0)20 7933 8780

Transense@walbrookpr.com

Notes to Editors:

 

Transense is a developer of specialist wireless sensor systems used to enable real-time data gathering and monitoring. Products include the patent protected Surface Acoustic Wave (SAW) sensor technology, used to improve equipment power, performance, reliability and efficiency; iTrack, Transense's Tyre Pressure Monitoring System, recently licensed to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal; and a range of intelligent tyre monitoring equipment under the Translogik brand. Target sectors include automotive, aerospace, industrial, green energy, rail and marine.

 

The Group's strategy is to maximise shareholder value through the delivery of sustained revenue growth from all three principal technologies - SAW, iTrack and Translogik probes - through leveraging excellence in innovation, know-how in commercialising technologies, industry partnerships and exposure to global growth markets.

 

Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999. www.transense.com

For further information please contact transense@walbrookpr.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMQQLFFBLLZFBV
Date   Source Headline
1st May 20247:00 amRNSDirector/PDMR - Acquisition of Shares
30th Apr 20245:00 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSTRT joins £37.8m LANDOne project with Airbus & ATI
17th Apr 20246:00 pmRNSTransaction in Own Shares & TVR
15th Apr 20242:51 pmRNSTransaction in Own Shares & TVR
28th Mar 20245:00 pmRNSTotal Voting Rights
25th Mar 20243:35 pmRNSTransaction in Own Shares & TVR
20th Mar 20249:10 amRNSRyan Maughan appointed as Managing Director
29th Feb 20245:00 pmRNSTotal Voting Rights
21st Feb 20242:40 pmRNSHolding(s) in Company
19th Feb 20247:00 amRNSInterim Results & Investor Presentation
15th Feb 20247:00 amRNSHolding(s) in Company
2nd Feb 20245:41 pmRNSTransaction in Own Shares & TVR
31st Jan 20245:00 pmRNSTotal Voting Rights
12th Jan 20247:00 amRNSDirector/PDMR Shareholding
11th Jan 20249:52 amRNSTransaction in Own Shares & TVR
8th Jan 20247:00 amRNSTranslogik Update – Appointment of Sales Director
1st Dec 20237:00 amRNSGrant of share options to Director and employee
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 202311:11 amRNSDirector/PDMR Shareholding
29th Nov 20233:01 pmRNSDirector/PDMR Shareholding
29th Nov 202310:45 amRNSResult of AGM
29th Nov 20237:00 amRNSAGM Statement & Trading Update
24th Nov 20231:11 pmRNSHolding(s) in Company
9th Nov 202312:12 pmRNSDirector/PDMR Shareholding
6th Nov 20234:48 pmRNSTransaction in Own Shares & TVR
25th Oct 202310:00 amRNSPosting of Annual Report & Notice of AGM
16th Oct 20233:23 pmRNSHolding(s) in Company
3rd Oct 20236:00 pmRNSHolding(s) in Company
28th Sep 20235:22 pmRNSHolding(s) in Company
27th Sep 20233:18 pmRNSHolding(s) in Company
26th Sep 20233:37 pmRNSDirector/PDMR Shareholding
25th Sep 202311:00 amRNSDirector/PDMR Shareholding
25th Sep 20237:00 amRNSFinal Results & Investor Presentation
22nd Sep 20239:25 amRNSHolding(s) in Company
31st Aug 20235:00 pmRNSTotal Voting Rights
29th Aug 20238:30 amRNSTransaction in Own Shares & TVR
23rd Aug 20237:00 amRNSNotice of Results & Investor Presentation
16th Aug 202310:03 amRNSHolding(s) in Company
11th Jul 20237:00 amRNSYear End Trading Update
30th Jun 20235:00 pmRNSTotal Voting Rights
22nd Jun 20234:24 pmRNSTransaction in own shares & TVR
19th Jun 20234:29 pmRNSHolding(s) in Company
16th Jun 20235:57 pmRNSTransaction in own shares & TVR
5th Jun 20237:00 amRNSSAW: Extension of scope of licence agreement
2nd Jun 20232:36 pmRNSTransaction in own shares & TVR
31st May 20235:00 pmRNSTotal Voting Rights
3rd May 20237:00 amRNSNew Automotive eDrive Business Contract
2nd May 202312:48 pmRNSAppointment of Non-Executive Director
2nd May 202310:23 amRNSTransaction in own shares & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.